Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Allantoin

  • Zoom
    Allantoin
  • Allantoin
Cat No: 30204
Biochemicals - More Biochemicals
Cayman

Allantoin is a product of purine and uric acid metabolism.{45992} It is formed through oxidation of uric acid by urate oxidase in most mammals but is formed only through non-enzymatic oxidation by free radicals in humans. Urinary levels of allantoin a...

More

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Synonyms:
  • N-(2,5-dioxo-4-imidazolidinyl)-urea
Correlated keywords:
  • 5377-33-3 37305-69-4 58308-55-7 DL 5Ureidohydantoin Allantion Allantol Cordianine Glyoxylic diureide Glyoxyldiureide Glyoxyldiureid NSC7606 SD101 Psoralon Sebical Septalan nonenzymatic
Product Overview:
Allantoin is a product of purine and uric acid metabolism.{45992} It is formed through oxidation of uric acid by urate oxidase in most mammals but is formed only through non-enzymatic oxidation by free radicals in humans. Urinary levels of allantoin are increased prior to the onset of Alzheimer’s disease symptoms in mice expressing mutations in amyloid precursor protein and tau (APP/tau) but not during the early/middle stage of the disease, indicating its potential use as a biomarker for predicting Alzheimer’s disease onset.{45993} Due to the formation of allantoin by free radicals in humans, increased urinary levels are a potential biomarker for oxidative stress status.{45992}
Size 25 g
Shipping dry ice
CAS Number 97-59-6
Molecular Formula C4H6N4O3
SMILES O=C1[C@@H](NC(N)=O)NC(N1)=O
Molecular Weight 158,1
Formulation A crystalline solid
Purity ≥95%
Custom Code 2933.21
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

Search